Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects.
Regazzi M, Maserati R, Villani P, Cusato M, Zucchi P, Briganti E, Roda R, Sacchelli L, Gatti F, Delle Foglie P, Nardini G, Fabris P, Mori F, Castelli P, Testa L. Regazzi M, et al. Among authors: cusato m. Antimicrob Agents Chemother. 2005 Feb;49(2):643-9. doi: 10.1128/AAC.49.2.643-649.2005. Antimicrob Agents Chemother. 2005. PMID: 15673746 Free PMC article. Clinical Trial.
Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.
Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: cusato m. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.
Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.
Regazzi M, Villani P, Gulminetti R, Cusato M, Brandolini M, Tinelli C, Barassi A, Maserati R, Sighinolfi L, D'Arminio Monforte A, Melzi D'Eril GV. Regazzi M, et al. Among authors: cusato m. Ther Drug Monit. 2011 Jun;33(3):303-8. doi: 10.1097/FTD.0b013e31821c2772. Ther Drug Monit. 2011. PMID: 21544015 Free article.
Sex differences in nevirapine disposition in HIV-infected patients.
Regazzi M, Villani P, Seminari E, Ravasi G, Cusato M, Marubbi F, Meneghetti G, Maserati R. Regazzi M, et al. Among authors: cusato m. AIDS. 2003 Nov 7;17(16):2399-400. doi: 10.1097/00002030-200311070-00018. AIDS. 2003. PMID: 14571195 No abstract available.
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.
Pinnetti C, Baroncelli S, Villani P, Fantoni M, Tozzi V, De Luca A, Cauda R, Anzidei G, Cusato M, Regazzi M, Floridia M, Tamburrini E. Pinnetti C, et al. Among authors: cusato m. J Antimicrob Chemother. 2010 Sep;65(9):2050-2. doi: 10.1093/jac/dkq264. Epub 2010 Jul 14. J Antimicrob Chemother. 2010. PMID: 20630894 No abstract available.
55 results